Skip to search.
 STI Down 0.31%
Streaming
Ticker Tape: On

Biogen Idec Inc. (BIIB)

-NasdaqGS
294.84 11.91(3.88%) 25 Apr 04:00 SGT
|After Hours : 292.74 Down 2.10 (0.71%) 25 Apr 07:01 SGT
Add to Portfolio
Prev Close:306.75
Open:306.99
Bid:280.00 x 100
Ask:296.00 x 100
1y Target Est:345.68
Beta:1.34
Earnings Date:21 Jul - 25 Jul (Est.)
Day's Range:286.48 - 308.72
52wk Range:194.66 - 358.89
Volume:2,385,364
Avg Vol (3m):1,815,480
Market Cap:69.70B
P/E (ttm):36.67
EPS (ttm):8.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):20.84
P/S (ttm):10.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :11.42
Quarterly EPS Est (Jun-14) :2.77
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback